Neuralstem secures patent for stem cell technology

01/26/2009 | American City Business Journals

Neuralstem has received a patent for its core technology that will allow it to grow nearly unlimited amounts of stem cells from all portions of the brain using a regulated and consistent process. This comes as the company prepares to study this year the safety and effectiveness of administering fetal stem cells into the spinal cords of people with Lou Gehrig's disease.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID